Headache Sciences Inc.
Headache Sciences Inc. is a clinical artificial intelligence company pioneering the diagnosis and monitoring of headache disorders, with a primary focus on migraine. Leveraging advanced EEG (electroencephalography) technology and machine learning, the company has developed the world's first objective test for migraine, aiming to address the global challenge of underdiagnosis and misdiagnosis. Their mission is to provide practitioners with innovative tools to improve diagnostics, monitoring, and treatment of headache-related neurogenic and neurodegenerative disorders. With a vision of translating brain electrical activity into a comprehensive suite of diagnostic and monitoring services, Headache Sciences Inc. stands at the forefront of Software as a Medical Device (SaMD) innovation, offering hope through discovery.
Industries
N/A
Nr. of Employees
small (1-50)
Patents
Products
EEG-based migraine diagnostic prototype (SaMD)
Prototype diagnostic system using machine-learning analysis of EEG to identify interictal migraine predisposition and subtype (migraine with aura, migraine without aura).
EEG-based migraine diagnostic prototype (SaMD)
Prototype diagnostic system using machine-learning analysis of EEG to identify interictal migraine predisposition and subtype (migraine with aura, migraine without aura).
Expertise Areas
- EEG signal processing
- Biomarker discovery and validation
- Machine learning for clinical diagnostics
- SaMD (software-as-a-medical-device) development
Key Technologies
- Electroencephalography (EEG)
- Machine learning classification (non-linear SVM)
- Biosignal signal processing
- Source localization for EEG
Key People
News & Updates
First company to win all stages of the Norman Esch Engineering Innovation & Entrepreneurship Awards back-to-back.
Received the Founder's Fellowship Award for innovation and entrepreneurship.
Awarded to students at Ryerson University for a clear plan of product testing with intentions to learn and iterate.
Peer-reviewed publication demonstrating proof of concept for the migraine diagnostic system using machine learning and EEG.
Publication presenting advances in EEG-based migraine classification.
A second super angel investor joined Headache Sciences Inc. in 2024, supporting the company's mission.
First company to win all stages of the Norman Esch Engineering Innovation & Entrepreneurship Awards back-to-back.
Received the Founder's Fellowship Award for innovation and entrepreneurship.
Awarded to students at Ryerson University for a clear plan of product testing with intentions to learn and iterate.
Peer-reviewed publication demonstrating proof of concept for the migraine diagnostic system using machine learning and EEG.
Publication presenting advances in EEG-based migraine classification.
A second super angel investor joined Headache Sciences Inc. in 2024, supporting the company's mission.